D. Gaál

687 total citations
38 papers, 552 citations indexed

About

D. Gaál is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, D. Gaál has authored 38 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in D. Gaál's work include Neuroendocrine Tumor Research Advances (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). D. Gaál is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Glycosylation and Glycoproteins Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). D. Gaál collaborates with scholars based in Hungary, United States and Germany. D. Gaál's co-authors include Ferenc Hudecz, Gábor Mező, Orsolya Csuka, M. Szekerke, I Blazsek, Judit Reményi, István Teplán, Gÿorgý Kéri, Imre Mező and Attila Kovács and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Controlled Release.

In The Last Decade

D. Gaál

38 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Gaál Hungary 15 327 127 96 69 67 38 552
M. Dhanasekaran United States 15 450 1.4× 62 0.5× 51 0.5× 26 0.4× 93 1.4× 41 754
Qian Zhong China 16 420 1.3× 209 1.6× 51 0.5× 21 0.3× 43 0.6× 41 862
Amor Hajri France 19 378 1.2× 346 2.7× 100 1.0× 26 0.4× 24 0.4× 34 1.0k
Lingling Geng China 14 547 1.7× 121 1.0× 60 0.6× 99 1.4× 24 0.4× 19 884
Ya Chun Wu Hong Kong 11 317 1.0× 82 0.6× 170 1.8× 27 0.4× 28 0.4× 13 546
Lídia M. Andrade Brazil 15 265 0.8× 70 0.6× 47 0.5× 30 0.4× 20 0.3× 39 622
Lilia Ileva United States 13 377 1.2× 117 0.9× 44 0.5× 73 1.1× 21 0.3× 16 794
Na Qu China 14 365 1.1× 92 0.7× 78 0.8× 39 0.6× 24 0.4× 56 754
I‐Ju Chen Taiwan 17 509 1.6× 133 1.0× 46 0.5× 111 1.6× 70 1.0× 40 839
Nicholas J. Burgoyne United Kingdom 9 422 1.3× 59 0.5× 29 0.3× 60 0.9× 44 0.7× 9 591

Countries citing papers authored by D. Gaál

Since Specialization
Citations

This map shows the geographic impact of D. Gaál's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Gaál with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Gaál more than expected).

Fields of papers citing papers by D. Gaál

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Gaál. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Gaál. The network helps show where D. Gaál may publish in the future.

Co-authorship network of co-authors of D. Gaál

This figure shows the co-authorship network connecting the top 25 collaborators of D. Gaál. A scholar is included among the top collaborators of D. Gaál based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Gaál. D. Gaál is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaál, D., et al.. (2012). A mixture of amino acids and other small molecules present in the serum suppresses the growth of murine and human tumors in vivo. International Journal of Cancer. 132(5). 1213–1221. 7 indexed citations
2.
Gaál, D., et al.. (2007). Avemar inhibits the growth of mouse and human xenograft mammary carcinomas comparable to endocrine treatments. Journal of Clinical Oncology. 25(18_suppl). 21132–21132. 3 indexed citations
3.
Gaál, D., et al.. (2006). Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor models.. PubMed. 26(5A). 3477–83. 12 indexed citations
4.
Mező, Gábor, Judit Reményi, Zsuzsa Májer, et al.. (2004). Synthesis, conformation, and immunoreactivity of new carrier molecules based on repeated tuftsin‐like sequence. Biopolymers. 73(6). 645–656. 34 indexed citations
5.
Molnár, Joséph, Ilona Mucsi, János Nacsa, et al.. (2004). New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.. PubMed. 24(2B). 865–71. 25 indexed citations
6.
Gaál, D., Orsolya Csuka, Axel Ullrich, et al.. (2003). The antitumour effect of the somatostatin analogue TT-232 depends on the treatment regimen. Cancer Detection and Prevention. 27(2). 155–162. 6 indexed citations
7.
Hudecz, Ferenc, Judit Reményi, Rita Szabó, et al.. (2003). Drug targeting by macromolecules without recognition unit?. Journal of Molecular Recognition. 16(5). 288–298. 14 indexed citations
8.
Radák, Zsolt, D. Gaál, Albert W. Taylor, et al.. (2002). Attenuation of the Development of Murine Solid Leukemia Tumor by Physical Exercise. Antioxidants and Redox Signaling. 4(1). 213–219. 18 indexed citations
9.
Radák, Zsolt, Anne Taylor, Mária Sasvári, et al.. (2001). Telomerase activity is not altered by regular strenuous exercise in skeletal muscle or by sarcoma in liver of rats. Redox Report. 6(2). 99–103. 19 indexed citations
10.
Reményi, Judit, Tamás Hegedűs, Szilárd Tóth, et al.. (2001). Daunomycin-polypetide conjugates: in vitro antitumor effect in sensitive and multidrug resistant cell lines. European Journal of Cancer. 37. S66–S66. 1 indexed citations
11.
Mező, Gábor, et al.. (2000). Synthesis and conformational studies of poly(l-lysine) based branched polypeptides with Ser and Glu/Leu in the side chains. Journal of Controlled Release. 63(1-2). 81–95. 18 indexed citations
12.
Gaál, D., et al.. (2000). In vivo antitumor activity of TT-232 a novel somatostatin analog.. PubMed. 19(4B). 3265–8. 6 indexed citations
13.
Gaál, D. & Ferenc Hudecz. (1998). Low toxicity and high antitumour activity of Daunomycin by conjugation to an immunopotential amphoteric branched polypeptide. European Journal of Cancer. 34(1). 155–161. 24 indexed citations
14.
15.
16.
Gaál, D., Ferenc Hudecz, & M. Szekerke. (1993). Significance of branched polypeptides in the mooulation of toxic side effects induced by radiation treatment. European Journal of Cancer. 29. S225–S225. 1 indexed citations
17.
Hudecz, Ferenc, D. Gaál, I. Kurucz, et al.. (1992). Carrier design: cytotoxicity and immunogenicity of synthetic branched polypeptides with poly(L-lysine) backbone. Journal of Controlled Release. 19(1-3). 231–243. 29 indexed citations
18.
Blazsek, I & D. Gaál. (1978). Endogenous Thymic Factors Regulating Cell Proliferation and Analysis of Their Mechanism of Action. Cell Proliferation. 11(3). 265–277. 17 indexed citations
19.
Balázs, András, et al.. (1977). Modulative effect of endogenous granuloid inhibitors on cell proliferation. Mechanisms of Ageing and Development. 6(3). 207–218. 4 indexed citations
20.
Blazsek, I, et al.. (1976). A multifactorial system controlling myeloid cell differentiation and division. Mechanisms of Ageing and Development. 5(1). 57–65. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Dhanasekaran Breakdown of academic impact, for papers by Qian Zhong Breakdown of academic impact, for papers by Amor Hajri Breakdown of academic impact, for papers by Lingling Geng Breakdown of academic impact, for papers by Ya Chun Wu Breakdown of academic impact, for papers by Lídia M. Andrade Breakdown of academic impact, for papers by Lilia Ileva Breakdown of academic impact, for papers by Na Qu Breakdown of academic impact, for papers by I‐Ju Chen Breakdown of academic impact, for papers by Nicholas J. Burgoyne
Rankless by CCL
2026